LUGPA 2014, Annual Meeting, November 6-8 / Chicago
LUGPA 2014
Annual Meeting
November 6-8 | Chicago
Hormone therapy plus current treatments improves survival in prostate cancer
March 23rd 2023Darolutamide increased overall survival compared to placebo in the overall patient population and patients with high-volume, high-risk mHSPC as well as in patients with low-risk metastatic hormone-sensitive prostate cancer.
2 Clarke Drive
Cranbury, NJ 08512